The future of cancer treatment is just around the corner
Thunder Biotech is developing a proprietary MOTO-CAR immunotherapy. MOTO-CAR technology modifies a cancer patients’ macrophages and enlists their own immune cells to recognize and attack solid tumors.
Thunder Biotech's purpose and passion is empowering patients to conquer cancer so they can live a joyful life, cancer free.
MOTO-CAR Immunotherapy: Innovative technology that modifies a tumor associated macrophage (TAM) with a CAR (Chimeric Antigen Receptor) designed to provide a more effective and humane treatment for patients with solid tumors—for your family and ours.
Empowering Patients to Conquer Cancer
When someone develops cancer, two things have happened: mutated cells accumulate, and the body’s immune system has failed to identify and eliminate them. It’s these unchecked, mutated cells that become cancer cells. Thunder Biotech is developing new therapies that help re-educate a patient’s immune system, restoring its ability to recognize and destroy cancer cells.
The ThunderBiotech Pipeline
The Promise of MOTO-CAR Immunotherapy
Traditional cancer treatments, including surgery, radiation, and chemotherapy, are invasive procedures that patients often find difficult to tolerate.
Thunder Biotech is working toward a more compassionate and effective cancer treatment. We are developing innovative MOTO-CAR immunotherapy treatments, which hold the promise of attacking solid tumors by activating a patient’s own immune system to eliminate cancer.
MOTO-CAR Immunotherapy
Thunder Biotech is a cancer immunotherapy company that has patented innovative treatments for cancer. This therapy enhances a patient’s own immune cells (turning macrophages into MOTO-CARs) to target specific biomarkers present on the surface of tumor cells. These MOTO-CARs have the ability to both identify cancer cells and engage the patients’ immune system to attack and destroy tumor cells.
This novel technology developed by Thunder Biotech has tremendous potential to help patients conquer cancer. With this new approach to fighting an old disease, Thunder Biotech is emerging as a leader in CAR (Chimeric Antigen Receptor) macrophage cancer immunotherapy.
Help us conquer cancer
Cancer claims millions of lives each year. In the United States, approximately 600,000 people die from cancer every year, which is over one person every minute. Worldwide, approximately 10 million people die each year from cancer — more than 19 deaths per minute.
It is very likely that you or someone you personally know and love has been diagnosed with cancer.
